
Erasca Faces Securities Class Action Over ERAS-0015 Data Claims
Investors who purchased Erasca, Inc. shares between January 14, 2025, and April 26, 2026, face an August 10, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit filed in the Southern District of California regarding alleged misrepresentations of clinical data.

























